Pro Medicus subsidiary Visage Imaging signs a 7-year contract with Luminis Health

Pro Medicus Limited (ASX: PME) announced that its 100% owned subsidiary Visage Imaging, Inc signed a AU$15 million 7-year contract with Luminis Health. As per the agreement, Visage Imaging will replace legacy PACS throughout the Luminis Health network. Based on the transactional licensing model, the contract will see the Company’s cloud-engineered Visage 7 Enterprise Imaging Platform along with Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout Luminis Health providing a unified diagnostic imaging platform across the network.

The Company highlighted that the planning for the rollout will start immediately and will be based on Visage’s proven cloud-based implementation process. The initial go-lives is targeted for 1H 2023.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com